nach oben

Journal of Bone and Mineral Metabolism

Erschienen in:

24.11.2022 | Original Article

The effect of ferritin levels on distal femoral cartilage thickness in patients with beta thalassaemia major

verfasst von: Alper Uysal, Gönül Oktay, Cihan Ural, Nimet Bilge Kalkan

Erschienen in: Journal of Bone and Mineral Metabolism | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Abstract

Introduction

To the best of our knowledge, the present study is the first in the literature to assess distal femoral cartilage thickness and its relationship with ferritin levels in adult patients with beta thalassaemia major (BTM).

Materials and methods

45 patients with BTM and 45 healthy controls were included in the study. Ferritin and haemoglobin levels of the patient and healthy groups were determined by blood analysis and distal femoral cartilage thicknesses were measured via ultrasound. Then, the patient group was divided into subgroups according to whether their ferritin levels were below or above 2500 µg/L. They were then compared among themselves and with the healthy control group using the available data.

Results

Distal femoral cartilage thickness values were statistically significantly lower in the BTM group compared to the healthy control group (p values < 0.001). Patients with a ferritin level below 2500 µg/L had statistically significantly higher right and left average distal femoral cartilage thickness values than the patients with a ferritin level above 2500 µg/L (p = 0.029 and p = 0.019, respectively). The right and left average distal femoral cartilage thickness values of the patient subgroup with low ferritin levels were statistically similar to the control group (p = 0.146 and p = 0.164, respectively).

Conclusion

Our study showed that thalassaemia patients are more likely to develop osteoarthritis (OA) than the normal population and possible OA development can be prevented by keeping the ferritin levels of these patients in the optimum range.

Rund D, Rachmilewitz E (2005) β-Thalassemia. N Engl J Med 353:1135–1146. https://doi.org/10.1056/NEJMra050436CrossRef

Galanello R, Origa R (2010) Beta-thalassemia. Orphanet J Rare Dis 5:1–15. https://doi.org/10.1186/1750-1172-5-11CrossRef

Taher AT, Cappellini MD (2018) How I manage medical complications of β-thalassemia in adults. Blood 132:1781–1791. https://doi.org/10.1182/blood-2018-06-818187CrossRef

Piga A (2017) Impact of bone disease and pain in thalassemia. Hematology Am Soc Hematol Educ Program 2017:272–277. https://doi.org/10.1182/asheducation-2017.1.272CrossRef

Noureldine MHA, Taher AT, Haydar AA, Berjawi A, Khamashta MA, Uthman I (2018) Rheumatological complications of beta-thalassaemia: an overview. Rheumatology 57:19–27. https://doi.org/10.1093/rheumatology/kex058CrossRef

Burton LH, Radakovich LB, Marolf AJ, Santangelo KS (2020) Systemic iron overload exacerbates osteoarthritis in the strain 13 guinea pig. Osteoarthr Cartil 28:1265–1275. https://doi.org/10.1016/j.joca.2020.06.005CrossRef

Nieuwenhuizen L, Schutgens R, Van Asbeck B, Wenting M, Van Veghel K, Roosendaal G, Biesma D, Lafeber F (2013) Identification and expression of iron regulators in human synovium: evidence for upregulation in haemophilic arthropathy compared to rheumatoid arthritis, osteoarthritis, and healthy controls. Haemophilia 19:e218–e227. https://doi.org/10.1111/hae.12208CrossRef

Oo WM, Bo MT (2016) Role of ultrasonography in knee osteoarthritis. J Clin Rheumatol 22:324–329. https://doi.org/10.1097/RHU.0000000000000436CrossRef

Yildizgoren MT, Helvaci MR, Ustun N, Osmanoglu K, Turhanoglu AD (2016) Ultrasonographic assessment of the distal femoral cartilage thickness in patients with homozygous sickle cell disease. Cartilage 7:217–221. https://doi.org/10.1177/1947603515614946CrossRef

10.

Ünal HU, Tok F, Adıgüzel E, Gezer M, Aydın İ, Yılmaz B, Oğuz Y (2016) Ultrasonographic evaluation of the femoral cartilage thickness in patients with chronic renal failure. Ren Fail 38:600–604. https://doi.org/10.3109/0886022X.2016.1149685CrossRef

11.

Bedewi MA, Elsifey AA, Naguib MF, Saleh AK, Nwihadh NB, Abd-Elghany AA, Swify SM (2020) Sonographic assessment of femoral cartilage thickness in healthy adults. Int J Med Res 48:0300060520948754. https://doi.org/10.1177/0300060520948754CrossRef

12.

Piercy KL, Troiano RP, Ballard RM, Carlson SA, Fulton JE, Galuska DA, George SM, Olson RD (2018) The physical activity guidelines for Americans. JAMA 320:2020–2028. https://doi.org/10.1001/jama.2018.14854CrossRef

13.

Aydinok Y (2018) Iron chelation therapy as a modality of management. Hematol Oncol Clin North Am 32:261–275. https://doi.org/10.1016/j.hoc.2017.12.002CrossRef

14.

Yıldızgören MT, Baki AE, Kara M, Ekiz T, Tiftik T, Tutkun E, Yılmaz H, Özçakar L (2015) Ultrasonographic measurement of the femoral cartilage thickness in patients with occupational lead exposure. J Expo Sci Environ Epidemiol 25:417–419. https://doi.org/10.1038/jes.2014.64CrossRef

15.

Carroll GJ, Breidahl W, Olynyk J (2011) Characteristics of the arthropathy described in hereditary hemochromatosis. Arthritis Care Res 64:9–14. https://doi.org/10.1002/acr.20501CrossRef

16.

Yao X, Sun K, Yu S, Luo J, Guo J, Lin J, Wang G, Guo Z, Ye Y, Guo F (2021) Chondrocyte ferroptosis contribute to the progression of osteoarthritis. J Orthop Translat 27:33–43. https://doi.org/10.1016/j.jot.2020.09.006CrossRef

17.

Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, Alnemri ES, Altucci L, Amelio I, Andrews DW (2018) Molecular mechanisms of cell death: recommendations of the Nomenclature committee on cell death 2018. Cell Death Differ 25:486–541. https://doi.org/10.1038/s41418-017-0012-4CrossRef

18.

Stockwell BR, Angeli JPF, Bayir H, Bush AI, Conrad M, Dixon SJ, Fulda S, Gascón S, Hatzios SK, Kagan VE (2017) Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell 171:273–285. https://doi.org/10.1016/j.cell.2017.09.021CrossRef

19.

Adamopoulos SG, Petrocheilou GM (2019) Skeletal radiological findings in thalassemia major. J Res Pract Musculoskeletal Syst 9:1–10

20.

Berkovitch M, Laxer RM, Koren G, Inman R, Olivieri N, Pritzker K, Fritzler M (1994) Arthropathy in thalassaemia patients receiving deferiprone. Lancet 343:1471–1472. https://doi.org/10.1016/S0140-6736(94)92585-2CrossRef

21.

Klement MR, Sharkey PF (2019) The significance of osteoarthritis-associated bone marrow lesions in the knee. J Am Acad Orthop Surg 27:752–759. https://doi.org/10.5435/JAAOS-D-18-00267CrossRef

22.

Sadatsuki R, Ishijima M, Kaneko H, Liu L, Futami I, Hada S, Kinoshita M, Kubota M, Aoki T, Takazawa Y (2019) Bone marrow lesion is associated with disability for activities of daily living in patients with early stage knee osteoarthritis. J Bone Miner Metab 37:529–536. https://doi.org/10.1007/s00774-018-0950-zCrossRef

23.

Elsayh KI, Zahran AM, El-Abaseri TB, Mohamed AO, El-Metwally TH (2014) Hypoxia biomarkers, oxidative stress, and circulating microparticles in pediatric patients with thalassemia in Upper Egypt. Clin Appl Thromb Hemost 20:536–545. https://doi.org/10.1177/1076029612472552CrossRef

24.

Alliston T, Hernandez CJ, Findlay DM, Felson DT, Kennedy OD (2018) Bone marrow lesions in osteoarthritis: what lies beneath. J Orthop Res 36:1818–1825. https://doi.org/10.1002/jor.23844CrossRef

25.

Ching K, Houard X, Berenbaum F, Wen C (2021) Hypertension meets osteoarthritis—revisiting the vascular aetiology hypothesis. Nat Rev Rheumatol 17:533–549. https://doi.org/10.1038/s41584-021-00650-xCrossRef

26.

Zhang H, Wang L, Cui J, Wang S, Han Y, Shao H, Wang C, Hu Y, Li X, Zhou Q (2022) Maintaining hypoxia environment of subchondral bone alleviates osteoarthritis progression. bioRxiv. https://doi.org/10.1101/2022.03.17.484053

27.

Cui Z, Crane J, Xie H, Jin X, Zhen G, Li C, Xie L, Wang L, Bian Q, Qiu T (2016) Halofuginone attenuates osteoarthritis by inhibition of TGF-β activity and H-type vessel formation in subchondral bone. Ann Rheum Dis 75:1714–1721. https://doi.org/10.1136/annrheumdis-2015-207923CrossRef

28.

Chen J, Hendriks M, Chatzis A, Ramasamy SK, Kusumbe AP (2020) Bone vasculature and bone marrow vascular niches in health and disease. J Bone Miner Res 35:2103–2120. https://doi.org/10.1002/jbmr.4171CrossRef

29.

Herrera HGA, Llinás P, Flórez L, Montes CB, Obando DV, Solorzano AD, Loaiza D, Astete CG (2020) Ultrasound measurement of femoral cartilage thickness in the knee of healthy young university students. Rev Esp Cir Ortop Traumatol 64:244–250. https://doi.org/10.1016/j.recote.2020.06.003CrossRef

30.

Naredo E, Acebes C, Möller I, Canillas F, de Agustín JJ, de Miguel E, Filippucci E, Iagnocco A, Moragues C, Tuneu R (2009) Ultrasound validity in the measurement of knee cartilage thickness. Ann Rheum Dis 68:1322–1327. https://doi.org/10.1136/ard.2008.090738CrossRef

31.

Ohashi S, Ohnishi I, Matsumoto T, Bessho M, Matsuyama J, Tobita K, Kaneko M, Nakamura K (2012) Measurement of articular cartilage thickness using a three-dimensional image reconstructed from B-mode ultrasonography mechanical scans feasibility study by comparison with MRI-derived data. Ultrasound Med Biol 38:402–411. https://doi.org/10.1016/j.ultrasmedbio.2011.11.019CrossRef

32.

Maeguchi K, Ito H, Morita Y, Furu M, Fujii T, Azukizawa M, Okahata A, Nishitani K, Kuriyama S, Nakamura S (2018) How precisely does ultrasonographic evaluation reflect the histological status of the articular cartilage of the knee joint? J Orthop 15:636–640. https://doi.org/10.1016/j.jor.2018.05.046CrossRef

33.

Kellenberger CJ, Schmugge M, Saurenmann T, Gennaro LD, Eber SW, Willi UV, Babyn PS (2004) Radiographic and MRI features of deferiprone-related arthropathy of the knees in patients with β-thalassemia. Am J Roentgenol 183:989–994. https://doi.org/10.2214/ajr.183.4.1830989CrossRef

34.

Chand G, Chowdhury V, Manchanda A, Singh S (2009) Deferiprone-induced arthropathy in thalassemia: MRI findings in a case. Indian J Radiol Imaging 19:155. https://doi.org/10.4103/0971-3026.50839CrossRef

35.

Calvo E, Palacios I, Delgado E, Ruiz-Cabello J, Hernandez P, Sanchez-Pernaute O, Egido J, Herrero-Beaumont G (2001) High-resolution MRI detects cartilage swelling at the early stages of experimental osteoarthritis. Osteoarthr Cartil 9:463–472. https://doi.org/10.1053/joca.2001.0413CrossRef

36.

Calvo E, Palacios I, Delgado E, Sanchez-Pernaute O, Largo R, Egido J, Herrero-Beaumont G (2004) Histopathological correlation of cartilage swelling detected by magnetic resonance imaging in early experimental osteoarthritis. Osteoarthr Cartil 12:878–886. https://doi.org/10.1016/j.joca.2004.07.007CrossRef

37.

Yildizgören M, Ekiz T, Nizamogullari S, Turhanoglu A, Guler H, Ustun N, Kara M, Özçakar L (2017) Effects of habitual knuckle cracking on metacarpal cartilage thickness and grip strength. Hand Surg Rehabil 36:41–43. https://doi.org/10.1016/j.hansur.2016.09.001CrossRef

38.

Martin JA, Buckwalter JA (2001) Roles of articular cartilage aging and chondrocyte senescence in the pathogenesis of osteoarthritis. Iowa Orthop J 21:1

39.

Atta D, Elsoaud AA, Hesham M, Beshir M, Elsaeed W, Mortada M, Ezzeldin N, Kelani H, Hassan M (2015) Frequency of musculoskeletal and otorhinolaryngologic manifestations in children with B-thalassemia. Int J Adv Res 3:959–969

40.

Soewondo W, Wibowo NA, Hanafi M, Irawan AT, Kusumaningrum S, Riza M, Probandari A, Maharina L (2020) Ferritin and genu joints ultrasound in major-beta thalassemia. GSC Adv Res Rev 5:101–109CrossRef

41.

Mokhtar GM, Tantawy AA, Tantawy W, Nassar N, Abdelmaksoud AA, Sakr H, Shams MA (2013) Clinical and radiological assessment of deferiprone related knee arthropathy in children with β-thalassemia major. Ain Shams Med J 64:675–689CrossRef

42.

Drakonaki E, Goumenakis M, Maragaki S, Klironomos V, Papadakis A, Sfakianaki E, Karantanas A (2010) Musculoskeletal ultrasonography in beta-thalassemia major. Euro Congr Radiol ECR 2010 C-2241. https://doi.org/10.1594/ecr2010/C-2241

43.

Burton LH, Afzali MF, Radakovich LB, Campbell MA, Culver LA, Olver CS, Santangelo KS (2022) Systemic administration of a pharmacologic iron chelator reduces cartilage lesion development in the Dunkin-Hartley model of primary osteoarthritis. Free Radic Biol Med 179:47–58. https://doi.org/10.1016/j.freeradbiomed.2021.12.257CrossRef

44.

Hassan MAM, Tolba OA (2016) Iron chelation monotherapy in transfusion-dependent beta-thalassemia major patients: a comparative study of deferasirox and deferoxamine. Electron Physician 8:2425CrossRef

45.

Olivieri NF, Nathan DG, MacMillan JH, Wayne AS, Liu PP, McGee A, Martin M, Koren G, Cohen AR (1994) Survival in medically treated patients with homozygous β-thalassemia. N Engl J Med 331:574–578. https://doi.org/10.1056/NEJM199409013310903CrossRef

Titel: The effect of ferritin levels on distal femoral cartilage thickness in patients with beta thalassaemia major
verfasst von: Alper Uysal
Gönül Oktay
Cihan Ural
Nimet Bilge Kalkan
Publikationsdatum: 24.11.2022
Verlag: Springer Nature Singapore
Erschienen in: Journal of Bone and Mineral Metabolism / Ausgabe 1/2023
Print ISSN: 0914-8779
Elektronische ISSN: 1435-5604
DOI: https://doi.org/10.1007/s00774-022-01384-w

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

The effect of ferritin levels on distal femoral cartilage thickness in patients with beta thalassaemia major

Abstract

Introduction

Materials and methods

Results

Conclusion

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

15% bedauern gewählte Blasenkrebs-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Innere Medizin

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Introduction

Materials and methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2023

Effect of vitamin D3 vs. calcifediol on VDR concentration and fiber size in skeletal muscle

Correction: Selenium-sensitive histone deacetylase 2 is required for forkhead box O3A and regulates extracellular matrix metabolism in cartilage

Change in prevalence of vertebral fractures over two decades: a Japanese medical examination-based study

Vitamin D deficiency in children with severe disabilities under limited ultraviolet exposure

The effect of the exercise environment and the level of involvement on bone mineral health

Fibroblast growth factor 8 (FGF8) up-regulates gelatinase expression in chondrocytes through nuclear factor-κB p65

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

15% bedauern gewählte Blasenkrebs-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Innere Medizin